Dividend Declaration

Summary by AI BETAClose X

JPMorgan American Investment Trust plc has declared an interim dividend of 2.75 pence per share, payable on 5th October 2026 to shareholders on record as of 28th August 2026, with an ex-dividend date of 27th August 2026. Shareholders have until 14th September 2026 to elect to participate in the Dividend Reinvestment Plan.

Disclaimer*

JPMorgan American IT PLC
19 August 2026
 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN AMERICAN INVESTMENT TRUST PLC

 

DIVIDEND DECLARATION

 

 

Legal Entity Identifier: 549300QNAI4XRPEB4G65

Information disclosed in accordance with DTR 6.1.13

 

The Board of JPMorgan American Investment Trust plc announces that an interim dividend of 2.75p will be paid on 5th October 2026 to shareholders on the register at the close of business on 28th August 2026. The ex-dividend date will be 27th August 2026.

 

The Company operates a Dividend Reinvestment Plan (DRIP) which is managed by the registrar, Computershare, and the deadline for elections under the DRIP (to start the plan from the interim dividend referred to above) is 14th September 2026. Shareholders holding their shares through specialist platforms may also be able to participate in a DRIP and should contact their providers for details.

 

 

 

19th August 2026

 

For further information, please contact:

 

Divya Amin

For and on behalf of

JPMorgan Funds Limited - Company Secretary

0800 20 40 20 or +44 1268 44 44 70

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100